Yael Flamand

10PUBLICATIONS
131CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 15, 2026
Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.

|Apr 20, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

|Apr 01, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Sri Vemulamanda, Aditi Kothari, Loris De Cecco

|Jun 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer.

Barbara Burtness, Yael Flamand, Harry Quon

|Apr 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.

Nabil F Saba, Yael Flamand, Derrick T Lin

|Oct 07, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.

Marlise R Luskin, Mark A Murakami, Julia Keating

Pageof 2

Frequent Collaborators

4 joint publications

Barbara Burtness

3 joint publications

Marlise R Luskin

3 joint publications

Daniel J DeAngelo

3 joint publications

Shai Shimony